- Home
- NGS vs AVIR Comparison
NGS vs AVIR Comparison
Compare NGS & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- AVIR
- Stock Information
- Founded
- NGS 1998
- AVIR 2012
- Country
- NGS United States
- AVIR United States
- Employees
- NGS N/A
- AVIR N/A
- Industry
- NGS Oilfield Services/Equipment
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- NGS Energy
- AVIR Health Care
- Exchange
- NGS Nasdaq
- AVIR Nasdaq
- Market Cap
- NGS 241.7M
- AVIR 247.5M
- IPO Year
- NGS 2002
- AVIR 2020
- Fundamental
- Price
- NGS $27.73
- AVIR $3.52
- Analyst Decision
- NGS Strong Buy
- AVIR Hold
- Analyst Count
- NGS 2
- AVIR 1
- Target Price
- NGS $26.50
- AVIR $6.88
- AVG Volume (30 Days)
- NGS 78.0K
- AVIR 548.6K
- Earning Date
- NGS 11-14-2024
- AVIR 02-26-2025
- Dividend Yield
- NGS N/A
- AVIR N/A
- EPS Growth
- NGS 605.21
- AVIR N/A
- EPS
- NGS 1.28
- AVIR N/A
- Revenue
- NGS $152,305,000.00
- AVIR N/A
- Revenue This Year
- NGS $30.81
- AVIR N/A
- Revenue Next Year
- NGS $13.48
- AVIR N/A
- P/E Ratio
- NGS $21.65
- AVIR N/A
- Revenue Growth
- NGS 41.72
- AVIR N/A
- 52 Week Low
- NGS $13.70
- AVIR $2.75
- 52 Week High
- NGS $28.50
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- NGS 61.67
- AVIR 66.91
- Support Level
- NGS $25.17
- AVIR $3.19
- Resistance Level
- NGS $26.08
- AVIR $3.32
- Average True Range (ATR)
- NGS 1.27
- AVIR 0.13
- MACD
- NGS 0.14
- AVIR 0.05
- Stochastic Oscillator
- NGS 89.49
- AVIR 89.58
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).